CDC Awards Contract to ACMT Obtain Critical Drug Overdose Data from the Toxicology Investigators Consortium
May 13, 2020 — ACMT’s ToxIC is a unique multicenter toxico-surveillance and research network comprised of physicians specifically qualified in the field of medical toxicology. Since the network’s establishment in 2010, there have been over 73,000 cases recorded into ToxIC’s Patient Registry from 40 participating sites across the United States comprised of more than 60 hospitals and clinics. This registry was designed to provide accurate and reliable data on overdose and adverse effects arising from exposures to medications, drugs of abuse, natural substances, metals, pesticides, or other chemical substances.
“ACMT is very honored to receive this contract from CDC for this important project related to drug overdose surveillance,” said Dr. Paul M. Wax, ACMT’s Executive Director and co-founder of ToxIC. “For over a decade, ACMT has worked diligently to develop the ToxIC Patient Registry as a useful tool for overdose surveillance. Particularly now, in the midst of the opioid overdose epidemic we anticipate this collaboration will deliver critical data that could improve public health decision making.”
This collaboration is expected to help CDC better characterize drug overdose and is consistent with the CDC’s mission to provide leadership in preventing and controlling injuries. The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology. Our members specialize in the prevention, evaluation, treatment, and monitoring of injury and illness from exposures to drugs and chemicals, as well as biological and radiological agents. ACMT members work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.